phantom tests use pre-generated deformation vector fields (DVFs) created using independent deformable registration software. These DVFs are recovered using a hybrid algorithm which is intensity based with the option to add guiding contours, and compared voxel-by-voxel. One hundred fifty registrations with true clinical images are evaluated where the ground truth is given by expert delineated contours and anatomic landmarks selected on the CBCT image sets. The contours are compared to the reference contours mapped by the DIR using DICE similarity coefficient (DSC) and mean distance between contours. The target registration error is computed for matched points. Registrations were evaluated by clinicians on a numerical scale indicating the qualitative acceptability for dose accumulation. Results: The virtual phantom DVFs were recovered with accuracy at or close to the tolerances suggested by TG-132 (95% of errors <2mm, max error < 5mm). Areas of larger deformation, >1cm, resulted in larger DVF errors, maximally up to 7mm. DIRs on clinical images appear consistently more accurate than rigid registrations: the mean DSC in prostate and head and neck improved from 0.79 to 0.91, and the mean TRE in the lung improved by 2mm. The addition of guiding contours, which adds time to the process, is recommended for prostate, but not for lung or head and neck. While mean errors are within the TG-132 guidelines (i.e. AE1 image voxel), there is no specification for the size of maximal errors for clinical data, which can be high (>5mm) when deformations are large. Qualitatively, 96% of the registrations were judged acceptable by expert reviewers for the purposes of dose accumulation, with poorer results being due to large deformation or artifacts in the CBCT images. Conclusion: The hybrid algorithm passed the acceptance testing on phantom and true clinical data, and is planned to be used to prospectively accumulate dose based on CT-CBCT DIRs, subject to individual review of each. Instances of increased registration errors (e.g. internal bladder filling) were noted and their impacts should be incorporated into clinical protocols and decision making. For the virtual phantoms, testing with well-known, standard image sets with realistic deformations is preferable to in-house generated test data; TG-132 tolerances may be more commensurate in this situation, and standard image sets will allow comparison between clinics.
Purpose/Objective(s): Regional nodal irradiation, including internal mammary (IM), supraclavicular (SCL), and axillary (Ax) nodes, has recently been shown to significantly impact the effectiveness of radiation treatment for breast cancer. Adequate radiation coverage of these nodal targets presents a unique challenge, compounded by the proximity of sensitive risk organs, such as lungs and heart. The aim of this study was to determine the optimal treatment technique for breast and regional node irradiation using hybrid volumetric modulated arc therapy (VMAT).
Materials/Methods: Ten (5 right, 5 left) breast/chest wall cases with nodal targets were randomly selected. Each case was contoured following guidelines of the NSABP-B51/RTOG 1304 protocol, and planned using both 3D conformal (3DCRT) and hybrid-VMAT techniques. 3DCRT plans utilized either opposed tangents, photon SC and/or Ax boost fields, and electron IM field, or wide tangents to cover breast and IM nodes and SC and/or Ax boost fields. Hybrid-VMAT plans utilized 3D opposed tangent fields to deliver 80% of the prescribed dose to the breast. Two opposed partial VMAT arcs were then used to deliver the remaining 20% of the prescription to the breast, and 100% of the prescription to the nodal targets. Each partial VMAT emulates the opposed tangential fields. A prescription of 50 Gy delivered in 25 fractions was used. Plans were compared and evaluated for target coverage and dose uniformity, dose to risk structures (heart, lung, contralateral breast), and treatment time. Differences were assessed for statistical significance (P<0.05) by use of Student's t-test. All plans were created using the Eclipse (Version 13.5) treatment planning system. Results: For the breast target, 3DCRT and hybrid-VMAT plans exhibited similar coverage (V 95% ) and conformity (P>0.05). For all nodal targets, however, hybrid-VMAT plans showed significantly improved coverage and dose uniformity (P < 0.001). In addition, hybrid-VMAT plans for right breast treatment provided significantly lower mean heart doses than 3DCRT (3.8Gy vs. 4.5Gy, P Z 0.03). Hybrid-VMAT plans also reduced the V 20Gy of the ipsilateral lung for both right and left breast treatment (21% vs. 27%). Hybrid-VMAT slightly increased the low dose volume of the contralateral breast (V 3Gy ) and lung (V 5Gy ) (P<0.001) for all cases. This might be due to increased head scatter. Finally, the hybrid-VMAT reduced the number of monitor units by 17% and the treatment time by 53%, as compared to 3DCRT. Conclusion: Hybrid-VMAT combines traditional tangential fields, guaranteeing skin flash, and removing uncertainty due to breast motion, with supplemental partial VMAT fields. This technique offers improved nodal target coverage, better normal tissue sparing, and shorter treatment times compared to traditional 3DCRT. In addition, uncertainty associated with field junction, necessary for 3DCRT, is also reduced. The hybrid-VMAT technique is a suitable replacement for 3DCRT for complex breast and nodal target irradiation. Purpose/Objective(s): Proton beam radiation therapy is given under the assumption that the relative biological effectiveness (RBE) for protons compared to photons is 1.1. Experimental data suggests that RBE varies with respect to tissue type, endpoint measured and dose weighted linear energy transfer (LET d ). Several equations have been proposed that predict RBE for a given LET d and suggest an approximately linear relationship. The first objective of this study was to create a simplified formula for RBE (2), external auditory canal, nasopharynx, and skin. Compared to our physical model, our biological model revealed several localized regions of increased dose. Implicated organs at risk include the oral cavity, mandible, temporomandibular joint, pharyngeal constrictor muscles, and brain. The biological model predicted substantially higher doses to these structures than the physical model (Table 1) .
Conclusion: Our biological model identified areas of potential toxicity that were not identifiable in the physical model and thus could influence the treatment planning process. Such areas will need to be monitored closely for signs of toxicity during treatment and in follow-up appointments. were performed to assess the differences of the recorded parameters before and after radiotherapy. Rank-sum tests were conducted to find parameters that may reflect response difference between different dose groups.
Results: After radiotherapy, both CTV mean K trans (p < .007) and s i (p < .002) significantly decreased. The volume ratio of BSV to CTV showed a decrease after radiotherapy (p < .003), and the decrease of BSV mean K trans were also found to be statistically significant (p < .001). For the patients in the 21Gy dose group, the relative BSV K trans values (post-RT value/pre-RT value) were significantly smaller (p < .045) than the values of the patients who received less than 21 Gy treatment dose. Conclusion: The initial results suggest that physiological biomarkers from transcytolemmal water exchange analysis significantly changed after radiotherapy. Changes in these biomarkers within the identified biological subvolume may have a role in predicting the clinical impact of radiation dose. Author Disclosure: C. Wang: None. J.K. Horton: None. F. Yin: Board member-at-large; AAPM. E. Subashi: None. Z. Chang: None.
